Authors: Morita, S Gebska, MA Kakkar, AK Scully, MF

Citation: S. Morita et al., High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity - Implications for cancer related thromboembolism and heparin therapy, THROMB HAEM, 86(2), 2001, pp. 616-622

Authors: Skordalakes, E Dodson, GG Green, DS Goodwin, CA Scully, MF Hudson, HR Kakkar, VV Deadman, JJ

Citation: E. Skordalakes et al., Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate, J MOL BIOL, 311(3), 2001, pp. 549-555

Authors: Green, D Elgendy, S Patel, G Skordalakes, E Goodwin, CA Scully, MF Kakkar, VV Deadman, JJ

Citation: D. Green et al., Substrate related O,O-dialkyldipeptidyl Psi carboxybenzylphosphonates, a new type of thrombin inhibitor, PHOSPHOR SU, 156, 2000, pp. 151-155

Authors: Monagle, P Adams, M Mahoney, M Ali, K Barnard, D Bernstein, M Brisson, L David, M Desai, S Scully, MF Halton, J Israels, S Jardine, L Leaker, M McCusker, P Silva, M Wu, J Anderson, R Andrew, M Massicotte, MP

Citation: P. Monagle et al., Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry, PEDIAT RES, 47(6), 2000, pp. 763-766

Authors: Green, D Skordalakes, E Scully, MF Goodwin, C Merette, S Burd, A Kakkar, VV Deadman, J

Citation: D. Green et al., X-ray crystallographic analyses of human alpha-thrombin complexed to peptidy aminophosphonates: Evidence of a binding mechanism, PHOSPHOR SU, 146, 1999, pp. 545-548